Cytokinetics Inc vs Diageo plc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Diageo plc trades at $94.54 (market cap $53.05B). The key difference: Diageo plc is far larger — about 5× Cytokinetics Inc's market cap, and Diageo plc pays a 3.5% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | DEO | |
|---|---|---|
Market Cap | $10.63B | $53.05B |
Sector | Technology | Technology |
52-Week High | $87.26 | $115.33 |
52-Week Low | $34.31 | $72.47 |
Enterprise Value | $10.74B | $72.54B |
Dividend Yield | — | 3.5% |
Trailing returns across standard periods
Latest headlines on both assets
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →